Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added new revision entry v3.4.3 with March 2026 dates; removed prior revision entry v3.4.2 and February 2026 dates.
    Difference
    0.3%
    Check dated 2026-03-11T14:41:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Results Posted with primary and secondary outcomes (ORR, CRR, PFS, OS) and related dates, including Results First Submitted/Posted timestamps. Also attached the Study Protocol and Statistical Analysis Plan PDF.
    Difference
    1%
    Check dated 2026-03-04T11:38:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added: Results Submitted and Revision: v3.4.2; Removed: No Results Posted and Revision: v3.4.1. The page now shows that results have been submitted and reflects the latest site revision.
    Difference
    0.4%
    Check dated 2026-02-11T02:17:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a site-wide notice about a funding lapse affecting information currency and a page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:27:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary display option and updated footer metadata to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed the older entries Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:21:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:58:22.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.